Filtered By:
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 2124 results found since Jan 2013.
Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" Vaccine 40(41) (2022) 5971-5996
Vaccine. 2023 Sep 1:S0264-410X(23)00787-9. doi: 10.1016/j.vaccine.2023.06.084. Online ahead of print.NO ABSTRACTPMID:37659892 | DOI:10.1016/j.vaccine.2023.06.084
Source: Vaccine - September 2, 2023 Category: Allergy & Immunology Authors: Matthew Palmer Kota Katanoda Eiko Saito Cecilia Acuti Martellucci Shiori Tanaka Sayaka Ikeda Haruka Sakamoto Dorothy Machalek Julia M L Brotherton Jane S Hocking Source Type: research
Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):912-919. doi: 10.15585/mmwr.mm7234a3.ABSTRACTThree vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). CDC analyzed data from the 2022 National Immunization Survey-Teen for 16,043 adolescents aged 13-17 years to assess vaccination coverage. Birth cohort analyses were conducted to assess trends in vaccination coverage by age 13 years (i.e., before the 13th birthday) and by age 14 years (i.e., before the 14th birthday) among adolescents who were due for routine vaccination before and dur...
Source: MMWR Morb Mortal Wkl... - August 24, 2023 Category: Epidemiology Authors: Cassandra Pingali David Yankey Laurie D Elam-Evans Lauri E Markowitz Madeleine R Valier Benjamin Fredua Samuel J Crowe Carla L DeSisto Shannon Stokley James A Singleton Source Type: research
Parental intention to vaccinate daughters with the human papillomavirus vaccine in Korea: a nationwide cross-sectional survey
CONCLUSION: The intention among parents to vaccinate daughters remains relatively low, although it is rising. To increase the HPV vaccination rate, strong recommendations and education should be provided to parents and the younger generation.PMID:37591785 | DOI:10.4178/epih.e2023076
Source: Cancer Control - August 17, 2023 Category: Cancer & Oncology Authors: Yejin Ha Kyeongmin Lee Bomi Park Mina Suh Jae Kwan Jun Kui Son Choi Source Type: research
Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein
PLoS One. 2023 Aug 15;18(8):e0290088. doi: 10.1371/journal.pone.0290088. eCollection 2023.ABSTRACTCervical cancer represents a global concern with 604,000 new cases and 342,000 deaths reported annually, with the vast majority diagnosed in low income countries. Despite high-risk Human Papillomavirus (HR HPV)-induced cervical cancer has become highly preventable through prophylactic vaccines, screening programs are critical in the control of cervical carcinogenesis in populations with limited access to vaccination and in older generations of women who have already been exposed to HR HPV infection. The surge of HPV molecular ...
Source: Cancer Control - August 15, 2023 Category: Cancer & Oncology Authors: Natalia E Contreras Julieta S Rold án Daniela S Castillo Source Type: research
A comparison of electronic health records and the Oregon state immunization registry for human papilloma virus vaccine delivery (2005-2022)
CONCLUSIONS: ALERT IIS data provides more accurate data than EHRs can provide when measuring vaccine delivery among adolescents in rural Oregon.PMID:37573204 | DOI:10.1016/j.vaccine.2023.08.017
Source: Vaccine - August 12, 2023 Category: Allergy & Immunology Authors: Sarah Bumatay Caitlin Dickinson Rex Larsen Isabel Stock Michael R Day Brigit Hatch Steven Robison Paul M Darden Eliana Sullivan Patricia A Carney Source Type: research
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
CONCLUSIONS: TTMV-HPV DNA surveillance testing yields few false negative results and few missed recurrences. These data could inform decisions on when to pursue re-imaging following first disease restaging and could inform future surveillance practice. Additional study of how pre-treatment TTMV-HPV DNA status impacts sensitivity for recurrence is needed.PMID:37566241 | DOI:10.1158/1078-0432.CCR-23-1478
Source: Cell Research - August 11, 2023 Category: Cytology Authors: Glenn J Hanna Scott A Roof James Jabalee Eleni M Rettig Rocco Ferrandino Sida Chen Marshall R Posner Krzysztof J Misiukiewicz Eric M Genden Raymond L Chai John Sims Elaine Thrash Scott J Stern Noah S Kalman Sreenija Yarlagadda Adam Raben Lydia Clements Ab Source Type: research
Breast and gynecologic cancers as a Brazilian health priority
CONCLUSION: Analyzed together, breast and gynecologic cancers correspond to the leading cause of cancer in Brazil. A heterogeneous group, female cancer includes diseases with a high primary and secondary prevention potential. The organization of a female cancer program in Brazil prioritizing primary and secondary prevention strategies, such as adequate mammography screening and human papillomavirus vaccination coverage, could significantly improve female cancer control in the country.PMID:37556639 | DOI:10.1590/1806-9282.2023S120
Source: Cancer Control - August 9, 2023 Category: Cancer & Oncology Authors: Ang élica Nogueira-Rodrigues Daniela Dornelles Rosa Daniele Assad Suzuki Eduardo Paulino Luciana Castro Garcia Landeiro Mariana Scaranti Marisa Riscalla Madi Paulo Marcelo Hoff Source Type: research
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses' attitudes towards designing and delivering a HPV educational intervention in post-primary schools for 15-17 year old students in Northern Ireland, UK
CONCLUSION: IMNs feel that they are the most appropriate professionals to design/deliver HPV education for 15-17 year old students. National policy change, based on collaboration between the Public Health Agency and Education Authority, is a key factor in facilitating IMNs to implement this school-based HPV education intervention.PMID:37543445 | DOI:10.1016/j.vaccine.2023.07.066
Source: Vaccine - August 5, 2023 Category: Allergy & Immunology Authors: Terri Flood Marian McLaughlin Ciara M Hughes Iseult M Wilson Source Type: research
